| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/09/2011 | WO2011047019A9 An objective, quantitative method to predict histological subtype in non-small cell lung cancer |
| 06/09/2011 | WO2011046597A8 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr |
| 06/09/2011 | WO2011035101A4 Diagnostic tests for abnormal ovarian conditions |
| 06/09/2011 | WO2011028578A3 Microfluidic interface |
| 06/09/2011 | WO2011028533A3 Methods for detecting dna methylation using encoded particles |
| 06/09/2011 | WO2011017696A3 Methods relating to aromatase inhibitor pharmacogenetics |
| 06/09/2011 | WO2011008349A3 Methods of identifying infectious disease and assays for identifying infectious disease |
| 06/09/2011 | WO2011003182A8 Methods for early detection of blood disorders |
| 06/09/2011 | WO2010142773A3 Semiconductor biosensors |
| 06/09/2011 | WO2010117804A3 Mostly natural dna sequencing by synthesis |
| 06/09/2011 | WO2010060186A8 Antibodies that specifically block the biological activity of a tumor antigen |
| 06/09/2011 | US20110138496 Polypeptide for improving tolerance to iron deficiency in plants, and use thereof |
| 06/09/2011 | US20110138488 Deficiency in the histone demethylase jhdm2a results in impaired energy expenditure and obesity |
| 06/09/2011 | US20110137839 Methods and systems for applying genetic operators to determine system conditions |
| 06/09/2011 | US20110137601 Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| 06/09/2011 | US20110137571 Meter having multi-level user interface |
| 06/09/2011 | US20110137131 Risk factors and prediction of myocardial infarction |
| 06/09/2011 | US20110137014 Super humanized antibodies |
| 06/09/2011 | US20110136913 Assessing and treating breast cancer patients |
| 06/09/2011 | US20110136865 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| 06/09/2011 | US20110136850 Methods and compositions for topoisomerase i modulated tumor suppression |
| 06/09/2011 | US20110136833 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof |
| 06/09/2011 | US20110136817 Methods of identifying responders to dopamine agonist therapy |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136745 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136690 Methods for identifying and monitoring drug side effects |
| 06/09/2011 | US20110136687 METHOD FOR DETERMINING THE DEGREE OF METHYLATION OF DEFINED CYTOSINES IN GENOMIC DNA IN THE SEQUENCE CONTEXT OF 5'-CpG-3' |
| 06/09/2011 | US20110136685 Method for determining a predisposition to basal cell carcinoma and for screening treatments thereof |
| 06/09/2011 | US20110136675 Identification and characterization of proteins using new database search modes |
| 06/09/2011 | US20110136264 Method for detecting target substance and target-substance detection kit |
| 06/09/2011 | US20110136263 Microbead analysis method and microbead analyzer |
| 06/09/2011 | US20110136262 Integrated microchip sensor system for detection of infectious agents |
| 06/09/2011 | US20110136261 Method of assaying complex and kit to be used therefor |
| 06/09/2011 | US20110136260 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching |
| 06/09/2011 | US20110136259 Immunoassay for cross-reacting substances |
| 06/09/2011 | US20110136258 Multiplanar Lateral Flow Assay with Sample Compressor |
| 06/09/2011 | US20110136257 Agglutination Based Sample Testing Device |
| 06/09/2011 | US20110136256 Methods and kits for decreasing interferences in plasma or serum containing assay samples of specific binding assays |
| 06/09/2011 | US20110136255 Composition and method for prediction of complicated disease course in crohn's disease |
| 06/09/2011 | US20110136254 alzheimer's diagnosis |
| 06/09/2011 | US20110136253 Irinotecan Immunoassay |
| 06/09/2011 | US20110136249 Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid |
| 06/09/2011 | US20110136247 Photoluminescent oxygen probe with reduced cross-sensitivity to humidity |
| 06/09/2011 | US20110136246 Novel oncogene nrf2 |
| 06/09/2011 | US20110136245 Synergistic interactions of phenolic compounds found in food |
| 06/09/2011 | US20110136244 Methods and kits for a color changing sample diluent |
| 06/09/2011 | US20110136243 High throughput method for analyzing the fatty acid composition in plasma phosphoglycerides |
| 06/09/2011 | US20110136242 Lanthanide Chelates and Use Thereof in Bioanalysis |
| 06/09/2011 | US20110136241 Type ii diabetes molecular bioprofile and method and system of using the same |
| 06/09/2011 | US20110136240 Diagnostic test for the detection of early stage liver cancer |
| 06/09/2011 | US20110136229 Novel lectin |
| 06/09/2011 | US20110136224 Mda-7 proteins and methods of use thereof |
| 06/09/2011 | US20110136223 Neurturin receptor |
| 06/09/2011 | US20110136172 Mammalian cytokines; related reagents |
| 06/09/2011 | US20110136164 Cartridge device for blood analysis |
| 06/09/2011 | US20110136163 Method of Toxicological Assessment |
| 06/09/2011 | US20110136161 Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease |
| 06/09/2011 | US20110136160 Analysis of glycated proteins |
| 06/09/2011 | US20110136155 Peptides and methods for the detection of lyme disease antibodies |
| 06/09/2011 | US20110136154 Voltage-gated metal-enhanced fluorescence, chemiluminescence or bioluminescence methods and systems |
| 06/09/2011 | US20110136153 Use of VEGF-D in the Diagnosis of Lymphangioleiomyomatosis (LAM) Disease |
| 06/09/2011 | US20110136152 Systems and methods for counting cells and biomolecules |
| 06/09/2011 | US20110136151 Assays for diagnosing and evaluating treatment options for pompe disease |
| 06/09/2011 | US20110136150 Method of Determination of Receptor Binding Saturation Effected by Monoclonal Antibodies |
| 06/09/2011 | US20110136149 Method for predicting the response to her2-directed therapy |
| 06/09/2011 | US20110136148 Monoclonal Antibodies Against GMF-B Antigens, and Uses Therefor |
| 06/09/2011 | US20110136147 Methods of identifying tumor associated glycoproteins |
| 06/09/2011 | US20110136146 Bioassay for polyq protein |
| 06/09/2011 | US20110136145 Methods for promoting fusion and reprogramming of somatic cells |
| 06/09/2011 | US20110136144 Fibroblast growth patterns for diagnosis of alzheimer's disease |
| 06/09/2011 | US20110136143 Modified cardiolipin and uses therefor |
| 06/09/2011 | US20110136142 Immunochromatography method |
| 06/09/2011 | US20110136141 Peptide reagents and method for inhibiting autoantibody antigen binding |
| 06/09/2011 | US20110136140 Diagnosis of systemic diseases |
| 06/09/2011 | US20110136139 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 06/09/2011 | US20110136138 Method for predicting a need for renal replacement therapy (rrt) |
| 06/09/2011 | US20110136137 Serum proteomic for finding diagnostic markers and for monitoring therapeutical intervention in treatment of hepatocellular carcinoma |
| 06/09/2011 | US20110136136 Methods For Detection Of Hydrophobic Drugs |
| 06/09/2011 | US20110136135 Apparatus and method for processing biological samples |
| 06/09/2011 | US20110136134 Method for Assessing the Damage of Keratin Fibers |
| 06/09/2011 | US20110136133 Method for differentiating between multiple sclerosis subtypes |
| 06/09/2011 | US20110136132 Immunodetection probe and method of immunodetection using the same |
| 06/09/2011 | US20110136131 Method for measuring enzyme activity and column for use in measuring enzyme activity |
| 06/09/2011 | US20110136130 Method for chromogenic detection of two or more target molecules in a single sample |
| 06/09/2011 | US20110136121 Method for detecting cancer |
| 06/09/2011 | US20110136116 Detection of target nucleic acid sequences using fluorescence resonance energy transfer |
| 06/09/2011 | US20110136112 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators |
| 06/09/2011 | US20110136111 Nucleic acid ligands against infectious prions |
| 06/09/2011 | US20110136107 Diagnostics and Therapeutics for Diseases Associated with G-Protein Coupled Receptor AdipoR2 (AdipoR2) |
| 06/09/2011 | US20110136103 Autoantibody enhanced immunoassays and kits |
| 06/09/2011 | US20110136100 Non-human animal disease model for hepatitis b virus-associated disease |
| 06/09/2011 | US20110136099 Multiplexed Analyses of Test Samples |
| 06/09/2011 | US20110136097 Method for determining origin of alcohol or sugar containing products |
| 06/09/2011 | US20110136022 Fuel cell, method for producing fuel cell, electronic apparatus, enzyme-immobilized electrode, biosensor, energy-conversion element, cells, organelles, and bacteria |
| 06/09/2011 | US20110135929 Multicolored particles |
| 06/09/2011 | US20110135784 Barley with low levels of hordeins |
| 06/09/2011 | US20110135764 Pest control using natural pest control agent blends |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135673 Epitope protection assay |